1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Cervical cancer

Topotecan for the treatment of recurrent and stage IVB cervical cancer

Technology appraisal guidance [TA183] Published: 28 October 2009

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • Appendix A: Appraisal Committee members and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
Download guidance (PDF)

Guidance

  • Next

6 Related NICE guidance

6 Related NICE guidance

  • High dose rate brachytherapy for carcinoma of the cervix. NICE interventional procedure guidance 160 (2006).

  • Guidance on the use of liquid-based cytology for cervical screening (review). NICE technology appraisal guidance 69 (2003).

  • National Institute for Health and Care Excellence (NICE)

  • Next